The observed amelioration of adjuvant-induced arthritis demonstratedmore robust control of the STAT3/p-STAT3 and JAK2/p-JAK2 pathways,indicating that these pathways hold significant promise as therapeuticstrategies for the management of RA. The gene discussed is JAK2; the disease is rheumatoid arthritis.